Fat signal fraction assessed with MRI predicts hepatic recurrence following hepatic resection for colorectal liver metastases

[1] Manfredi S(2006)Epidemiology and management of liver metastases fromcolorectal cancer Ann Surg 244 254-259

[2] Hackl C(2014)Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma BMC Cancer 14 810-716

[3] Engstrand J(2018)Colorectal cancer liver metastases - a population-based study on incidence, management and survival BMC Cancer 18 78-101

[4] Nilsson H(2020)Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review Hepatobiliary Surg Nutr 9 705-177

[5] Strömberg C(1989)The distribution of secondary growths in cancer of the breast. 1889 Cancer Metastasis Rev 8 98-1002

[6] Jonas E(2012)The tumor microenvironment Surg Oncol 21 172-158

[7] Freedman J(2021)Tumor microenvironment in metastatic colorectal cancer: the arbitrator in patients' outcome Cancers (Basel) 13 1130-853

[8] Margonis GA(2017)Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases Br J Surg 104 990-396

[9] Kreis ME(2021)Hepatic steatosis in patients undergoing resection of colorectal liver metastases: a target for prehabilitation? A narrative review Cancer and hepatic steatosis ESMO Open 6 100185-195

[10] Wang JJ(2019)Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases Surg Oncol 30 147-558

[1] Manfredi S(2006)Epidemiology and management of liver metastases fromcolorectal cancer Ann Surg 244 254-259

[2] Hackl C(2014)Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma BMC Cancer 14 810-716

[3] Engstrand J(2018)Colorectal cancer liver metastases - a population-based study on incidence, management and survival BMC Cancer 18 78-101

[4] Nilsson H(2020)Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review Hepatobiliary Surg Nutr 9 705-177

[5] Strömberg C(1989)The distribution of secondary growths in cancer of the breast. 1889 Cancer Metastasis Rev 8 98-1002

[6] Jonas E(2012)The tumor microenvironment Surg Oncol 21 172-158

[7] Freedman J(2021)Tumor microenvironment in metastatic colorectal cancer: the arbitrator in patients' outcome Cancers (Basel) 13 1130-853

[8] Margonis GA(2017)Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases Br J Surg 104 990-396

[9] Kreis ME(2021)Hepatic steatosis in patients undergoing resection of colorectal liver metastases: a target for prehabilitation? A narrative review Cancer and hepatic steatosis ESMO Open 6 100185-195

[10] Wang JJ(2019)Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases Surg Oncol 30 147-558